SEC Form 4 · accession 0001645627-17-000114
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Sep 1, 2017
Accepted (ET)
Sep 7, 2017 · 10:54 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2017 | P | 3,000 | $0.0276 | A | 22,886,189 | D | |
| Common Stock | Sep 1, 2017 | P | 3,000 | $0.0263 | A | 22,889,189 | D | |
| Common Stock | Sep 1, 2017 | P | 5,000 | $0.0259 | A | 22,894,189 | D | |
| Common Stock | Sep 1, 2017 | P | 3,000 | $0.026 | A | 22,897,189 | D | |
| Common Stock | Sep 1, 2017 | P | 5,000 | $0.0259 | A | 22,902,189 | D | |
| Common Stock | Sep 5, 2017 | P | 3,000 | $0.025 | A | 22,905,189 | D | |
| Common Stock | Sep 5, 2017 | P | 3,000 | $0.0259 | A | 22,908,189 | D | |
| Common Stock | Sep 5, 2017 | P | 3,000 | $0.0259 | A | 22,911,189 | D | |
| Common Stock | Sep 5, 2017 | P | 3,000 | $0.0259 | A | 22,914,189 | D | |
| Common Stock | Sep 5, 2017 | P | 3,000 | $0.0252 | A | 22,917,189 | D | |
| Common Stock | Sep 5, 2017 | P | 5,000 | $0.0252 | A | 22,922,189 | D | |
| Common Stock | Sep 5, 2017 | P | 5,000 | $0.0252 | A | 22,927,189 | D | |
| Common Stock | Sep 5, 2017 | P | 5,000 | $0.0252 | A | 22,932,189 | D | |
| Common Stock | Sep 5, 2017 | P | 5,000 | $0.0252 | A | 22,937,189 | D | |
| Common Stock | Sep 5, 2017 | P | 5,000 | $0.0258 | A | 22,942,189 | D | |
| Common Stock | Sep 5, 2017 | P | 7,000 | $0.0252 | A | 22,949,189 | D | |
| Common Stock | Sep 5, 2017 | P | 5,000 | $0.0252 | A | 22,954,189 | D | |
| Common Stock | Sep 5, 2017 | P | 5,000 | $0.0252 | A | 22,959,189 | D | |
| Common Stock | Sep 5, 2017 | P | 5,000 | $0.0252 | A | 22,964,189 | D | |
| Common Stock | Sep 5, 2017 | P | 5,000 | $0.0252 | A | 22,969,189 | D | |
| Common Stock | Sep 5, 2017 | P | 5,000 | $0.0252 | A | 22,974,189 | D | |
| Common Stock | Sep 5, 2017 | P | 5,000 | $0.0252 | A | 22,979,189 | D | |
| Common Stock | Sep 5, 2017 | P | 10,000 | $0.0252 | A | 22,989,189 | D | |
| Common Stock | Sep 5, 2017 | P | 7,000 | $0.0251 | A | 22,996,189 | D | |
| Common Stock | Sep 5, 2017 | P | 20,000 | $0.0252 | A | 23,016,189 | D | |
| Common Stock | Sep 5, 2017 | P | 10,000 | $0.0252 | A | 23,026,189 | D | |
| Common Stock | Sep 5, 2017 | P | 30,000 | $0.0252 | A | 23,056,189 | D | |
| Common Stock | Sep 5, 2017 | P | 10,000 | $0.0252 | A | 23,066,189 | D | |
| Common Stock | Sep 5, 2017 | P | 5,000 | $0.0258 | A | 23,071,189 | D | |
| Common Stock | Sep 5, 2017 | P | 3,000 | $0.0258 | A | 23,074,189 | D |
Table II — derivative securities
No Table II lines on this filing.